The Controversy of Contrast-Induced Nephropathy With Intravenous Contrast: What Is the Risk?

Area of Science:

• Nephrology
• Radiology
• Clinical Medicine

Background:

• Contrast-induced nephropathy (CIN) is a recognized complication of intravenous contrast media.
• Recent studies challenge the historical understanding of CIN's prevalence and severity.
• Previous research was limited by confounding factors like chronic kidney disease and lack of prophylactic measures.

Purpose of the Study:

• To re-evaluate the risk of CIN in patients undergoing contrast-enhanced studies.
• To provide a refined risk classification for CIN based on renal function.
• To guide clinical decision-making regarding contrast administration.

Main Methods:

• Review and analysis of existing experimental and clinical studies on CIN.
• Application of propensity score-adjusted models to mitigate selection bias.
• Classification of CIN risk based on estimated glomerular filtration rate (eGFR) thresholds.

Main Results:

• Patients with eGFR ≥ 45mL/min/1.73m² have a negligible risk of CIN.
• Patients with eGFR < 30mL/min/1.73m² are at high risk for CIN.
• Intermediate CIN risk is observed for eGFR between 30-44mL/min/1.73m², with increased risk if diabetes mellitus is present.

Conclusions:

• A nuanced approach to CIN risk assessment is necessary.
• Risk stratification using eGFR is crucial for patient management.
• The benefits of contrast-enhanced studies must be weighed against CIN risk in high-risk patients.